NIH-funded research U01 cooperative agreement

Sleep Apnea, Memory, and Alzheimer's Disease in World Trade Center Responders

Official title: Role of Sleep Apnea in Cognition and Alzheimer's Disease Biomarkers in WTC Responders

Funded at Icahn School of Medicine at Mount Sinai · NIH-11070195 · Data updated 2026-11-12

This project looks at how sleep apnea might be connected to memory changes and early signs of Alzheimer's disease in people who responded to the World Trade Center events.

More s Disease research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionIcahn School of Medicine at Mount Sinai
NIH-funded
Lab location1 site (New York, United States)
Project startJuly 1, 2021
Project endJune 30, 2026
Funding year2025
Award (this year)$590,612
NIH project number5U01OH011852-05
Project IDNIH-11070195 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this type of research would be World Trade Center responders with or without sleep apnea and varying degrees of cognitive function.

Less likely to help

Patients whose cognitive decline is not related to sleep disturbances or Alzheimer's disease biomarkers may not directly benefit from this specific line of inquiry.

What this research studies

We are exploring the link between sleep apnea and changes in memory and thinking, as well as specific markers in the body that suggest a risk for Alzheimer's disease. Our team is focusing on World Trade Center responders because many of them experience sleep apnea and have shown early signs of memory issues. We want to understand if sleep problems like sleep apnea contribute to brain changes related to Alzheimer's, or if sleep disturbances are an early sign of the disease itself. By looking at these connections, we hope to find ways to help protect brain health in this unique group.

Why it matters

Potential benefit: If successful, this work could identify sleep apnea as a modifiable risk factor for Alzheimer's disease, potentially leading to new strategies for prevention or early intervention in at-risk individuals.

How similar studies have gone: Previous data from this team and others suggest a connection between increased sleep apnea severity and higher amyloid beta burden, indicating a promising area for further investigation.

Where this research is happening

  • Icahn School of Medicine at Mount Sinai
    New York, United States
    Active

Researchers

  • Principal investigator: Ayappa, Indu a — Icahn School of Medicine at Mount Sinai
  • Study coordinator: Ayappa, Indu a

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.